Evotec SE American Depositary Shares (EVO)
Stock · NASDAQ · Health Care
$1.91as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support Reject97.1%
High Beta49.9%
Resistance level
$1.93
Industry
Biotechnology: Pharmaceutical Preparations
About EVO
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidne…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 4,461
- Website
- www.evotec.com/
Fundamentals
- 1-day range
- $1.91$1.95
- Market cap
- $172.06M
- P/E (trailing)
- —
- P/E (forward)
- -10.05
- EPS (trailing)
- $-1.09
- Dividend yield
- —
- Beta
- 2.05
- Avg. volume
- 53.8K
52-week range
$3.18$7.3
Next earnings: November 5, 2026 · EPS estimate $-0.30confirmed
Forecasts
4 analyst ratings
Buy 42%
Hold 58%
Sell 0%
1-year price forecast
High
$6.89
+260.7%
Median
$3.21
+68.3%
Low
$2.01
+5.2%
Evotec SE American Depositary Shares Competitors
Chosen by industry and closest market cap.
- EVOEvotec SE American Depositary Shares$1.91▼ 2.80%Market cap $172.06MP/E —$3.18$7.3
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$15.19▼ 6.06%Market cap $170.54MP/E —$5.5$24.17
- TNXPTonix Pharmaceuticals Holding Corp. Common Stock$13.59▲ 0.18%Market cap $170.01MP/E —$9.4$34.04
- LFCRLifecore Biomedical Inc. Common Stock$4.58▲ 0.88%Market cap $164.67MP/E —$3.63$8.98
- OKUROnKure Therapeutics Inc. Class A Common Stock$3.78▼ 1.31%Market cap $162.39MP/E —$2.23$5.38
- NBPNovaBridge Biosciences American Depositary Shares$1.85▼ 2.38%Market cap $185.76MP/E —$1.46$6.79
- AARDAardvark Therapeutics Inc. Common Stock$5.71▼ 13.75%Market cap $154.94MP/E —$3.35$17.94
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EVO Evotec SE American Depositary Shares | $172.06M | — | $1.91 | ▼ 2.80% | $3.18$7.3 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $170.54M | — | $15.19 | ▼ 6.06% | $5.5$24.17 |
| TNXP Tonix Pharmaceuticals Holding Corp. Common Stock | $170.01M | — | $13.59 | ▲ 0.18% | $9.4$34.04 |
| LFCR Lifecore Biomedical Inc. Common Stock | $164.67M | — | $4.58 | ▲ 0.88% | $3.63$8.98 |
| OKUR OnKure Therapeutics Inc. Class A Common Stock | $162.39M | — | $3.78 | ▼ 1.31% | $2.23$5.38 |
| NBP NovaBridge Biosciences American Depositary Shares | $185.76M | — | $1.85 | ▼ 2.38% | $1.46$6.79 |
| AARD Aardvark Therapeutics Inc. Common Stock | $154.94M | — | $5.71 | ▼ 13.75% | $3.35$17.94 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Evotec Q2 EPS $(0.15) Misses $(0.06) Estimate, Sales $166.802M Miss $212.370M EstimateBenzinga · 8/13/2026
- Evotec Affirms FY2026 Sales Guidance of $667.470M-$714.310M vs $673.750M EstBenzinga · 8/13/2026
- Odyssey Taps Evotec's AI-Driven Discovery Platform To Advance Autoimmune, Inflammatory Disease ProgramsBenzinga · 8/6/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 8.15M
- Total value held
- $20.19M
- Institutional holders
- 45
Top holders this quarter
- Unknown4.60M
- Unknown1.07M
- Unknown627.3K
- Unknown509.1K
- Unknown283.6K
- Unknown259.7K
- Unknown122.3K
- Unknown119.4K
- Unknown99.6K
- Unknown87.2K
See the full, filterable feed with live charts on the MarketWall dashboard.